Javascript must be enabled to continue!
The Binding of EGFR to GM1(3) Hosted in Lipid Raft-Like Biomembranes Insighted by Plasmonic Resonance Techniques
View through CrossRef
We exploit Au/SiO2plasmonic structures to check the effective binding activity of GM1(3) gangliosides hosted in physiological-like biomembranes, in presence of the Epidermal Growth Factor Receptor (EGFR). To this aim, we used bilayers that support the propagation of optical surface plasmon modes (plasmonic transducers, PTs) or guided modes (Plasmon Waveguide Resonators, PWRs). First, we measured the binding of EGFR to GM1(3) by using PTs. Indeed, effective interactions were evidenced, but with faint signals that prevented resolving dissociation kinetics. In order to enhance the optical responses, we turned our attention to PWRs. We first refined the design of a previously adopted Au/SiO2PWR, finding that the nominal sensitivity is independent on SiO2thickness but strongly dependent on its residual losses, due typically to a nonoptimal deposition process. We fabricated an improved Au/SiO2resonator and tested the predicted signal enhancement by monitoring the binding of EGFR to GM3-enriched biomembranes. The measured signal was ~12-fold higher than that one measured using a PT, close to the maximum theoretical enhancement. The higher PWR response enabled us to detect the dissociation of EGFR from GM3, and the value of the apparent dissociation constant of the GM3-EGFR complex could be obtained.
Title: The Binding of EGFR to GM1(3) Hosted in Lipid Raft-Like Biomembranes Insighted by Plasmonic Resonance Techniques
Description:
We exploit Au/SiO2plasmonic structures to check the effective binding activity of GM1(3) gangliosides hosted in physiological-like biomembranes, in presence of the Epidermal Growth Factor Receptor (EGFR).
To this aim, we used bilayers that support the propagation of optical surface plasmon modes (plasmonic transducers, PTs) or guided modes (Plasmon Waveguide Resonators, PWRs).
First, we measured the binding of EGFR to GM1(3) by using PTs.
Indeed, effective interactions were evidenced, but with faint signals that prevented resolving dissociation kinetics.
In order to enhance the optical responses, we turned our attention to PWRs.
We first refined the design of a previously adopted Au/SiO2PWR, finding that the nominal sensitivity is independent on SiO2thickness but strongly dependent on its residual losses, due typically to a nonoptimal deposition process.
We fabricated an improved Au/SiO2resonator and tested the predicted signal enhancement by monitoring the binding of EGFR to GM3-enriched biomembranes.
The measured signal was ~12-fold higher than that one measured using a PT, close to the maximum theoretical enhancement.
The higher PWR response enabled us to detect the dissociation of EGFR from GM3, and the value of the apparent dissociation constant of the GM3-EGFR complex could be obtained.
Related Results
Abstract 5463: Development of a novel antibody-maytansinoid conjugate, IMGN289, for the treatment of EGFR-expressing solid tumors.
Abstract 5463: Development of a novel antibody-maytansinoid conjugate, IMGN289, for the treatment of EGFR-expressing solid tumors.
Abstract
EGFR is an attractive target for the treatment of a variety of solid tumors because of its role as a driver oncogene and high level of expression. Four EGFR...
Chronic Kidney Disease Predicts Adverse Major Cardiovascular Events and Adverse Limb Events in Patients With Diabetes and Peripheral Arterial Disease
Chronic Kidney Disease Predicts Adverse Major Cardiovascular Events and Adverse Limb Events in Patients With Diabetes and Peripheral Arterial Disease
This study aims to explore the effect in each stage of chronic kidney disease (CKD) on the major adverse cardiovascular events (MACE) in diabetes mellitus (DM) patients with periph...
Effects of cyclodextrins on GM1-gangliosides in fibroblasts from GM1-gangliosidosis patients
Effects of cyclodextrins on GM1-gangliosides in fibroblasts from GM1-gangliosidosis patients
Abstract
Objectives
GM1-gangliosidosis is an inherited disorder characterized by the accumulation of GM1-gangliosides in many ti...
Human IgM monoclonal proteins that bind 3-fucosyllactosamine, asialo-GM1, and GM1.
Human IgM monoclonal proteins that bind 3-fucosyllactosamine, asialo-GM1, and GM1.
Abstract
Analysis of monoclonal human Ig that occur in association with lymphoproliferative diseases has provided valuable information about antibody structure and i...
Plasma ctDNA biomarker study in patients with non-small cell lung cancer with EGFR exon 20 insertion mutation treated with sunvozertinib.
Plasma ctDNA biomarker study in patients with non-small cell lung cancer with EGFR exon 20 insertion mutation treated with sunvozertinib.
8563 Background: There are limited reports on biomarker studies of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutation (exon...
Regulation of Transmembrane Signaling by Ganglioside GM1 :
Regulation of Transmembrane Signaling by Ganglioside GM1 :
Abstract : Interaction of antibodies to ganglioside GM1 with Neuro2a
cells was studied to investigate the role of GM1 in cell signaling. Binding of
anti‐GM1 to Neuro2a cells in...
Abstract 6596: High affinity chimeric antigen receptors with cross reactivity to clinically relevant EGFR mutated proteins
Abstract 6596: High affinity chimeric antigen receptors with cross reactivity to clinically relevant EGFR mutated proteins
Abstract
Introduction:
Glioblastoma (GBM) is malignant and aggressive brain tumor with a median overall survival of 14.6 months, despite the developme...
Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness.
Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness.
NCTC 2071 cells are unable to synthesize the monosialoganglioside GM1. When grown in chemically defined medium these cells contained no detectable GM1 and did not accumulate 3': 5'...

